Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.

Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.

Item
http://www.wikidata.org/entity/Q33211346
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyA phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolA phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.Advances in oral delivery of anti-cancer prodrugs.A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860

Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors.

Item
http://www.wikidata.org/entity/Q33211346
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@ast
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@en
type
label
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@ast
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@en
prefLabel
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@ast
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Phase I and pharmacokinetic st ...... in patients with solid tumors.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698